Pennsylvania – MJ Shareholders https://mjshareholders.com The Ultimate Marijuana Business Directory Thu, 27 Oct 2022 17:30:02 +0000 en-US hourly 1 https://wordpress.org/?v=6.5.3 TILT Holdings Expands Partnership with Highsman, Launching “H” by Ricky Williams in Pennsylvania https://mjshareholders.com/tilt-holdings-expands-partnership-with-highsman-launching-h-by-ricky-williams-in-pennsylvania/ Thu, 27 Oct 2022 17:30:02 +0000 https://www.cannabisfn.com/?p=2966896

Ryan Allway

October 27th, 2022

News, Top News


Kick off with Pregame, Halftime and Postgame medical marijuana

PHOENIX, Oct. 27, 2022 (GLOBE NEWSWIRE) — TILT Holdings Inc. (“TILT” or the “Company”) (NEO: TILT) (OTCQX: TLLTF), a global provider of cannabis business solutions that include inhalation technologies, cultivation, manufacturing, processing, brand development and retail, today announced the Pennsylvania launch of “H” by Ricky Williams, the former NFL player’s medical marijuana brand. The purpose-driven brand will be distributed to dispensaries throughout the Commonwealth of Pennsylvania for medical marijuana patients through TILT subsidiary Standard Farms.

Motivated by his own personal journey with medical marijuana and healing, Williams’ brand, more widely known as Highsman, launched in November 2021 to inspire greatness and promote wellness in athletes and sports fans. The brand is now available in five states with Pennsylvania marking its second state launch in partnership with TILT. The initial product collection offering includes flower 8ths in:

  • Pregame, energizing and attention-grabbing sativas;
  • Halftime, balanced and restorative hybrids; and
  • Postgame, restful and recovery-focused indicas.

“This brand line, more specifically marijuana, has profoundly and positively impacted my life,” said Ricky Williams, founder of “H” by Ricky Williams. “I introduced these products to break through the stigma of marijuana and improve access to those seeking to be the best versions of themselves. Thanks to our partnership with TILT, we can introduce even more patients to the benefits and healing properties of medical marijuana through our brand.”

“TILT’s differentiated brand-partner model allows us to collaborate with some of the most innovative and impactful brands in the U.S. and introduce them to new markets,” said Gary Santo, Chief Executive Officer of TILT. “I am proud to be working with Ricky to bring this authentic brand to patients in Pennsylvania.”

Pennsylvania patients can find “H” by Ricky Williams branded products throughout the state via the TILT wholesale channel. Dispensaries in Pennsylvania that are interested in “H” by Ricky Williams or other TILT brand partner portfolio products from 1906Airo, or Old Pal, should contact our wholesale team at [email protected] to order or save a spot on our Launch List.

Keep up-to-date on progress on our social media:
Instagram: @tiltholdings @Highsman
Twitter: @TILT_Holdings @Highsman

About TILT
TILT helps cannabis businesses build brands. Through a portfolio of companies providing technology, hardware, cultivation and production, TILT services brands and cannabis retailers across 37 states in the U.S., as well as Canada, Israel, South America and the European Union. TILT’s core businesses include Jupiter Research LLC, a wholly-owned subsidiary and leader in the vaporization segment focused on hardware design, research, development and manufacturing; and cannabis operations, Commonwealth Alternative Care, Inc. in Massachusetts, Standard Farms LLC in Pennsylvania, Standard Farms Ohio, LLC in Ohio, and its partnership with the Shinnecock Indian Nation in New York. TILT is headquartered in Phoenix, Arizona. For more information, visit www.tiltholdings.com.

About “H” by Ricky Williams

H” by Ricky Williams, known nationally as Highsman, is the cannabis lifestyle brand created by Ricky Williams, entrepreneur, thought leader and one of the most electric NFL running backs of the century, to empower professional and everyday athletes and sports enthusiasts alike. “H” by Ricky Williams offers premium quality cannabis and a collection of apparel and accessories designed to complement an elevated lifestyle on and off the field. For more information, please visit www.highsman.com.

Forward-Looking Information

This news release contains forward-looking information and statements (together, “forward-looking information”) under applicable Canadian and U.S. securities laws which are based on current expectations. Forward-looking information is provided for the purpose of presenting information about TILT management’s current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. Forward-looking information may include, without limitation, the expected performance of the collaboration between TILT, Standard Farms and Highsman, anticipated development, timing and release of future product offerings, the opinions or beliefs of management, prospects, opportunities, priorities, targets, goals, ongoing objectives, milestones, strategies, and outlook of TILT, and includes statements about, among other things, future developments, future operations, strengths and strategy of TILT. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “will”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. These statements should not be read as guarantees of future performance or results. These statements are based upon certain material factors, assumptions and analyses that were applied in drawing a conclusion or making a forecast or projection, including TILT’s experience and perceptions of historical trends, the ability of TILT to maximize shareholder value and expand its operations, current conditions and expected future developments, as well as other factors that are believed to be reasonable in the circumstances.

Although such statements are based on management’s reasonable assumptions at the date such statements are made, there can be no assurance that it will be completed on the terms described above and that such forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such forward-looking information. Accordingly, readers should not place undue reliance on the forward-looking information. TILT assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by applicable law.

By its nature, forward-looking information is subject to risks and uncertainties, and there are a variety of risk factors, many of which are beyond the control of TILT, and that may cause actual outcomes to differ materially from those discussed in the forward-looking information. Such risk factors include, but are not limited to, those described under the heading “Risk Factors” in Amendment No. 2 to the Form 10 Registration Statement filed by TILT with the United States Securities and Exchange Commission and on SEDAR at www.sedar.com.

Company Contact:
Lynn Ricci, VP of Investor Relations & Corporate Communications
TILT Holdings Inc.
[email protected]

Investor Relations Contact:
Sean Mansouri, CFA
Elevate IR
[email protected]
720.330.2829

Media Contact:
Leland Radovanovic
Trailblaze
[email protected]

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


]]>
Curaleaf Expands Pennsylvania Retail Presence with Dispensary Openings in State College and Erie https://mjshareholders.com/curaleaf-expands-pennsylvania-retail-presence-with-dispensary-openings-in-state-college-and-erie/ Fri, 18 Feb 2022 16:07:47 +0000 https://www.cannabisfn.com/?p=2938074

Ryan Allway

February 18th, 2022

News, Top News


Newest Dispensaries Expand Company’s Retail Presence to 16 Locations in Fast Growing Pennsylvania Medical Market, and 127 Nationwide

WAKEFIELD, Mass., Feb. 18, 2022 /PRNewswire/ — Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer products in cannabis, today announced the opening of its State College dispensary, located at 1248 S Atherton St, State College PA 16801. One additional location, Curaleaf Erie, located at 7891 Peach St., is expected to open in early March, pending final regulatory approvals. Curaleaf’s latest locations in State College and Erie will increase the Company’s footprint to 16 dispensaries statewide and 127 across the country.

Curaleaf State College is a beacon of education and advancement in patient care throughout the state of Pennsylvania. Patients that walk through the doors of the Company’s newest dispensary will have access to an array of Curaleaf products such as vaporizers, concentrates and whole flower products, including Select Elite, Select Elite Live, Grassroots Full-Spectrum RSOs, RSO capsules, prepackaged flower, and more. Patients can also safely access the store’s full offerings by ordering online at their convenience.

On Monday, February 21, the State College location will host a grand opening celebration which will include an 8:45 a.m. ET ribbon cutting with Chamber of Business & Industry of Centre County, and will follow with vendor pop-ups from 12:00 p.m. to 2:00 pm ET. In honor of the opening, Curaleaf donated $5,000 to Central Pennsylvania Food Bank.The Company also celebrated grand openings Wayne and Greensburg by allocating charitable donations to local Pennsylvania-based nonprofits including Urban Affairs Coalition, Balanced Veterans Network.

“Curaleaf is excited to begin serving our newest patient communities in State College and Erie through our premium medical products and inclusive retail experiences,” said Curaleaf Chief Executive Officer Joe Bayern. “Expanding our presence within Pennsylvania enables us to further support our patients by providing them with quality products and service to make confident and informed decisions about their medical marijuana journeys.”

In addition to Curaleaf’s latest locations, the Company also serves patients in Altoona, Bradford, Brookville, City Avenue, DuBois, Gettysburg, Greensburg Harrisburg, Horsham, King of Prussia, Lebanon, Morton, Philadelphia and Wayne. In the coming weeks, Curaleaf will offer grand opening discounts to veterans, seniors, students and first-time patients at all Pennsylvania locations. For more information on store openings, along with product offerings and hours of operation, please visit https://curaleaf.com/dispensary/pennsylvania.

About Curaleaf Holdings
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf”) is a leading international provider of consumer products in cannabis with a mission to improve lives by providing clarity around cannabis and confidence around consumption. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf and Select, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. In the United States, Curaleaf currently operates in 23 states with 126 dispensaries, 26 cultivation sites, and employs over 5,200 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.

Forward Looking Statements
This media advisory contains forward–looking statements and forward–looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as “plans”, “expects” or, “proposed”, “is expected”, “intends”, “anticipates”, or “believes”, or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward–looking statements and information concerning the opening of two new dispensaries in the state of Pennsylvania. Such forward-looking statements and information reflect management’s current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and risks and uncertainties is contained under “Risk Factors and Uncertainties” in the Company’s latest annual information form filed April 28, 2021, which is available under the Company’s SEDAR profile at http://www.sedar.com, and in other filings that the Company has made and may make with applicable securities authorities in the future. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward looking statements contained in this press release. The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.

INVESTOR CONTACT
Curaleaf Holdings, Inc.
Investor Relations
[email protected]

MEDIA CONTACT
Curaleaf Holdings, Inc.
Tracy Brady, VP Corporate Communications
[email protected]

SOURCE Curaleaf Holdings, Inc.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


]]>
A Marijuana Legalization Bill That Supports Social Equity Is Being Created By Pennsylvania Legislators https://mjshareholders.com/a-marijuana-legalization-bill-that-supports-social-equity-is-being-created-by-pennsylvania-legislators/ Thu, 30 Sep 2021 02:45:30 +0000 https://marijuanastocks.com/?p=49524 Lawmakers In Pennsylvania Are Working To Legalize Marijuana

The post A Marijuana Legalization Bill That Supports Social Equity Is Being Created By Pennsylvania Legislators appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

]]>

<!– (adsbygoogle = window.adsbygoogle || []).push({ google_ad_client: “ca-pub-5707738102681835”, enable_page_level_ads: true }); –>A Marijuana Legalization Bill That Supports Social Equity Is Being Created By Pennsylvania Legislators – Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.<img src="https://s.w.org/images/core/emoji/15.0.3/72x72/2122.png" alt="™" class="wp-smiley" style="height: 1em; max-height: 1em;" />

<!– Click –>

]]>
Cansortium Opens New Dispensary in Mechanicsburg, Pennsylvania https://mjshareholders.com/cansortium-opens-new-dispensary-in-mechanicsburg-pennsylvania/ Fri, 20 Aug 2021 22:20:26 +0000 https://www.cannabisfn.com/?p=2930667

Ryan Allway

August 20th, 2021


MIAMIAug. 20, 2021 /PRNewswire/ – Cansortium Inc. (CSE: TIUM.U) (OTCQX: CNTMF) (“Cansortium” or the “Company”), a vertically-integrated cannabis company operating under the Fluent™ brand, today announced the opening of Fluent Mechanicsburg, the Company’s 2nd retail location in Pennsylvania and its 28th dispensary overall.

The new dispensary is located at 6200 Carlisle Pike, Mechanicsburg, PA 17050. This 4,000+ ft2 location is in a small shopping center with ample parking, right off one of the principal commercial roads in the HarrisburgCarlisle metropolitan area. Fluent Mechanicsburg will offer patients a broad assortment of cannabis products, including whole flower, oil cartridges, tinctures and concentrates.

“We are thrilled to open our second dispensary in Pennsylvania and begin serving the great community of Mechanicsburg and Cumberland County,” said CEO Robert Beasley. “Pennsylvania is one of the largest medical cannabis markets in the country—on pace to do more than $1 billion of annual sales in 2021—and we are in the early innings of capitalizing on strong growth in the state. Our medical dispensary permit allows for three different retail locations, and we remain on track to open our third store later this year.”

The Fluent brand continually strives to set the standard for premium quality, consistently formulated cannabis products. All Fluent products in the Company’s Florida dispensaries use high-quality cannabis that is cultivated, processed, and packaged in strict compliance with Florida regulations. For consumers, the sleek, modern dispensaries provide a warm, welcoming and professional environment, with private consultation rooms and knowledgeable staff who carefully guide patients in selecting the right products and carefully safeguard patient privacy.

For a complete list of Fluent dispensary locations, current promotions, rewards programs and hours of operation, or to explore the entire Fluent product line and place an online order for home delivery anywhere in Florida, please visit www.getfluent.com.

About Cansortium Inc.
Cansortium is a vertically-integrated cannabis company with licenses and operations in FloridaPennsylvaniaMichigan and Texas. The Company operates under the Fluent™ brand and is dedicated to being one of the highest quality cannabis companies for the communities it serves. This is driven by Cansortium’s unrelenting commitment to operational excellence in cultivation, production, distribution and retail. The Company is headquartered in Miami, Florida.

Cansortium Inc.’s common shares trade on the CSE under the symbol “TIUM.U” and on the OTCQX Best Market under the symbol “CNTMF.” For more information about the Company, please visit www.getfluent.com.

Forward-Looking Information
Certain information in this news release may constitute forward-looking information. In some cases, but not necessarily in all cases, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “targets”, “expects” or “does not expect”, “is expected”, “an opportunity exists”, “is positioned”, “estimates”, “intends”, “assumes”, “anticipates” or “does not anticipate” or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might”, “will” or “will be taken”, “occur” or “be achieved”. In addition, any statements that refer to expectations, projections, or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts but instead represent management’s expectations, estimates, and projections regarding future events.

Forward-looking information is necessarily based on many opinions, assumptions, and estimates that, while considered reasonable by the Company as of the date of this news release, are subject to known and unknown risks, uncertainties, assumptions, and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information, including but not limited to the factors described in the public documents of the Company available at www.sedar.com. These factors are not intended to represent a complete list of the factors that could affect the Company; however, these factors should be considered carefully. There can be no assurance that such estimates and assumptions will prove to be correct. The forward-looking statements contained in this news release are made as of the date of this news release, and the Company expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.

For further information: www.getfluent.com

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


]]>
TILT Enters Into Three State Agreement To Manufacture and Distribute 1906-Branded Rapid Onset Cannabis Products https://mjshareholders.com/tilt-enters-into-three-state-agreement-to-manufacture-and-distribute-1906-branded-rapid-onset-cannabis-products/ Thu, 12 Aug 2021 14:43:29 +0000 https://www.cannabisfn.com/?p=2929222

Ryan Allway

August 12th, 2021


1906, a cannabis product innovator, is the creator of highly functional formulations that combine moderately-dosed cannabis with targeted plant medicines

TILT to launch 1906 Drops in Pennsylvania and Ohio, as well as the 1906 line of chocolates in the Massachusetts market

PHOENIX, Aug. 12, 2021 (GLOBE NEWSWIRE) — TILT Holdings Inc. (“TILT or the “Company”) (CSE: TILT) (OTCQX: TLLTF), a global provider of business solutions to the cannabis industry that includes inhalation technologies, cultivation, manufacturing, processing, brand development and retail, announced a multi-state licensing agreement with cannabis product innovator brand 1906 (“1906”).

Through its subsidiaries Standard Farms, LLC in Pennsylvania, Standard Farms Ohio, LLC and Commonwealth Alternative Care, Inc. (“CAC”) in Massachusetts, TILT will provide full-service wholesale manufacturing, packaging and distribution services to accelerate the availability of 1906’s portable, non-smokable cannabis products to patients in the rapidly-growing adult-use and medical markets that TILT serves.

Since coming to market in Colorado in 2016, 1906 has been one of the fastest growing brands in the U.S. Pending regulatory approval, later this year TILT expects to launch 1906’s zero-calorie, allergen-free pills (“Drops”) in Pennsylvania and Ohio, as well as 1906’s line of premium chocolates in Massachusetts, where their Drops are currently available to both medical patients and adult-use consumers. 1906 products are designed to deliver six unique experiences including*:

  • Go – A special blend of plant medicines, caffeine, and cannabis promoting alertness, energy, and focus. Each Go Drop contains 5mg THC and 5mg CBD.
  • Genius – An optimal blend of five plant medicines, caffeine, and cannabis promoting cognitive performance. Each Genius Drop contains 2.5mg THC and 2.5mg CBD.
  • Bliss – A stimulating blend of euphoria-inducing plant medicines and cannabis promoting a bubbly sense of well-being and extroverted happiness. Each Bliss Drop contains 5mg THC and 5mg CBD.
  • Love – An aphrodisiac made from five exotic herbs renowned for their love-enhancing properties, plus cannabis to increase sensuality. ​​Each Love Drop contains 2.5mg THC and 2.5mg CBD.
  • Chill – A perfectly balanced blend of stress-reducing plant medicines and relaxing cannabis promoting a tranquil mind and a calm body. Each Chill Drop contains 5mg THC and 25mg CBD.
  • Midnight – A highly targeted blend of sleep-inducing plant medicines and relaxing cannabis promoting deeper and more restful nights. Each Midnight Drop contains 5mg THC and 5mg CBD.

“Since announcing our brand partnership strategy earlier this year, we continue to attract some of the most exciting and unique brands in the space,” said Gary Santo, CEO of TILT Holdings. “1906 marks another stellar addition to our growing roster of brand partners, and their willingness to enter into multiple markets with us reinforces the value proposition we offer our partners as well as 1906’s faith and trust in TILT’s ability to deliver. Our team continues to perform at a high level, and as we seek to create value for our shareholders, I could not be more proud of our ability to execute.”

“1906 is committed to making cannabis accessible, easy and unintimidating for all users. We’re thrilled to join forces with a partner who has the expertise and operational systems to help us reach more patients as we continue our eastward expansion,” says 1906 Co-founder and CEO Peter Barsoom. “TILT has brought a host of impressive brands to the marketplace—they have what it takes to help us scale production and distribution in key states.”

*Due to differing state regulations, not all products will be immediately available in all markets.

About TILT
TILT helps cannabis businesses build brands. Through a portfolio of companies providing technology, hardware, cultivation and production, TILT services brands and cannabis retailers across 35 states in the U.S., as well as Canada, Israel, Mexico, South America and the European Union. TILT’s core businesses include Jupiter Research, LLC , a wholly owned subsidiary and leader in the vaporization segment focused on hardware design research and manufacturing; and cannabis operations CAC in Massachusetts and Standard Farms, LLC in Pennsylvania. For more information, visit www.tiltholdings.com

About 1906
1906 is a leader in innovative self-care, creating groundbreaking functional formulations combining cannabis and plant medicines, currently available in four states. 1906’s lineup delivers six distinctive experiences that promote sleep, energy, arousal, relaxation, cognitive focus, and a happy mood, all in consistently fast-acting formulations using organically-grown, pesticide-free cannabis. User-friendly, portable and thoughtfully engineered, they deliver curated effects within 20 minutes—faster than any other edible on the market. The rapid-onset formulations help consumers get the most out of their days and nights while staying pleasantly in control. For more information on 1906, please visit www.1906newhighs.com.

Forward-Looking Information
This news release contains forward-looking information based on current expectations. Forward-looking information is provided for the purpose of presenting information about management’s current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. Forward looking information may include, without limitation, Standard Farms, PA, Standard Farms, OH, and CAC’s ability to successfully manufacture and distribute 1906 products in Pennsylvania, Ohio and Massachusetts, the expected launch of new 1906 products, expected attributes of new 1906 products, the success of TILT’s brand strategy, the opinions or beliefs of management, prospects, opportunities, priorities, targets, goals, ongoing objectives, milestones, strategies and outlook of TILT, and includes statements about, among other things, future developments, the future operations, strengths and strategy of TILT. Generally, forward looking information can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. These statements should not be read as guarantees of future performance or results. These statements are based upon certain material factors, assumptions and analyses that were applied in drawing a conclusion or making a forecast or projection, including TILT’s experience and perceptions of historical trends, the ability of TILT to maximize shareholder value, current conditions and expected future developments, as well as other factors that are believed to be reasonable in the circumstances.

Although such statements are based on management’s reasonable assumptions at the date such statements are made, there can be no assurance that it will be completed on the terms described above and that such forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such forward-looking information. Accordingly, readers should not place undue reliance on the forward-looking information. TILT assumes no responsibility to update or revise forward- looking information to reflect new events or circumstances unless required by applicable law.

By its nature, forward-looking information is subject to risks and uncertainties, and there are a variety of material factors, many of which are beyond the control of TILT, and that may cause actual outcomes to differ materially from those discussed in the forward-looking statements.

For additional information regarding forward-looking statements and their related risks, please refer to the “Risk Factors and Uncertainties” section in the Management Discussion and Analysis of the Company for the quarter ended on March 31, 2021, which is available on the Company’s SEDAR profile at www.sedar.com.

The CSE has neither approved nor disapproved the contents of this news release.

Investor Relations Contact:
Taylor Allison
[email protected]

Media Contact:
Juliet Fairbrother
MATTIO Communications
[email protected]
631.338.5343

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


]]>
TerrAscend Closes Previously Announced Acquisition of Keystone Canna Remedies https://mjshareholders.com/terrascend-closes-previously-announced-acquisition-of-keystone-canna-remedies/ Mon, 03 May 2021 14:05:34 +0000 https://www.cannabisfn.com/?p=2919797

Ryan Allway

May 3rd, 2021


Acquires Three Operating Dispensaries in Northeast Pennsylvania

Purchase Price Represents a Mid-Single Digit Multiple of KCR’s Expected 2021 EBITDA

NEW YORK and TORONTOMay 3, 2021 /CNW/ – TerrAscend Corp. (“TerrAscend” or the “Company”) (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis operator, today reported it has closed the previously announced acquisition of GuadCo, LLC and KCR Holdings LLC (collectively “KCR”) for an implied enterprise value of US$70 million (the “transaction”). The transaction adds three retail dispensaries located in BethlehemAllentown and Stroudsburg to complement the Company’s existing retail footprint in Southeastern Pennsylvania.

As an operator of three well managed dispensaries in the Northeast region, KCR expands TerrAscend’s retail footprint, diversifies the Company’s customer base and enhances margins through deeper vertical integration of its market leading brands Kind Tree, Ilera, and Prism.

“With the closing of this acquisition, TerrAscend doubles our owned footprint to six dispensaries and further solidifies our leadership position as a branded manufacturer in Pennsylvania, where we distribute our products to 100% of the dispensaries in the Commonwealth,” said Jason Wild, Executive Chairman of TerrAscend.

Transaction Details
TerrAscend previously owned 10% of KCR and has acquired the remaining 90% of the equity for total consideration of $63 million, comprised of $36 million in stock, $20.25 million in cash and a $6.75 million note. The purchase price is expected to represent a mid-single digit multiple of KCR’s 2021 EBITDA.

The Canadian Securities Exchange (“CSE”) has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

About TerrAscend
TerrAscend is a leading North American cannabis operator with vertically integrated operations in PennsylvaniaNew Jersey, and California in addition to operating as a licensed producer in Canada. TerrAscend operates an award-winning chain of Apothecarium dispensary retail locations as well as scaled cultivation, processing and manufacturing facilities on both the East and West coasts. TerrAscend’s best-in-class cultivation and manufacturing practices yield consistent, high-quality cannabis, providing industry-leading product selection to both the medical and legal adult-use market. The Company owns several synergistic businesses and brands, including The Apothecarium, Ilera Healthcare, Kind Tree, Prism, State Flower, Valhalla Confections, and Arise Bioscience Inc. For more information, visit www.terrascend.com.

Forward Looking Information
This news release contains “forward-looking information” within the meaning of applicable securities laws. Forward-looking information contained in this press release may be identified by the use of words such as, “may”, “would”, “could”, “will”, “likely”, “expect”, “anticipate”, “believe, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook” and other similar expressions, and include statements with respect to future revenue and profits. Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors relevant in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment; and the availability of licenses, approvals and permits.

Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. Such risks and uncertainties include, but are not limited to, current and future market conditions; risks related to federal, state, provincial, territorial, local and foreign government laws, rules and regulations, including federal and state laws in the United States relating to cannabis operations in the United States; and the risk factors set out in the Company’s most recently filed MD&A, filed with the Canadian securities regulators and available under the Company’s profile on SEDAR at www.sedar.com.

The statements in this press release are made as of the date of this release. The Company disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

Caution Regarding Cannabis Operations in the United States
Investors should note that there are significant legal restrictions and regulations that govern the cannabis industry in the United States. Cannabis remains a Schedule I drug under the US Controlled Substances Act, making it illegal under federal law in the United States to, among other things, cultivate, distribute or possess cannabis in the United States. Financial transactions involving proceeds generated by, or intended to promote, cannabis-related business activities in the United States may form the basis for prosecution under applicable US federal money laundering legislation.

While the approach to enforcement of such laws by the federal government in the United States has trended toward non-enforcement against individuals and businesses that comply with medical or adult-use cannabis programs in states where such programs are legal, strict compliance with state laws with respect to cannabis will neither absolve TerrAscend of liability under U.S. federal law, nor will it provide a defense to any federal proceeding which may be brought against TerrAscend. The enforcement of federal laws in the United States is a significant risk to the business of TerrAscend and any proceedings brought against TerrAscend thereunder may adversely affect TerrAscend’s operations and financial performance.

SOURCE TerrAscend

For further information: Keith Stauffer, Chief Financial Officer, [email protected]; Daniel Foley, SVP, Treasurer, [email protected]

Related Links

https://www.terrascend.com/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

Ryan Allway

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


]]>
TerrAscend Doubles Dispensary Footprint in Pennsylvania Through Acquisition of Keystone Canna Remedies https://mjshareholders.com/terrascend-doubles-dispensary-footprint-in-pennsylvania-through-acquisition-of-keystone-canna-remedies/ Tue, 20 Apr 2021 15:51:31 +0000 https://www.cannabisfn.com/?p=2918791

Ryan Allway

April 20th, 2021


Acquires Three Operating Dispensaries in Northeast Pennsylvania

Purchase price represents a mid-single digit multiple of KCR’s expected 2021 EBITDA

NEW YORK and TORONTOApril 20, 2021 /CNW/ – TerrAscend Corp. (“TerrAscend” or the “Company”) (CSE:TER) (OTCQX: TRSSF), a leading North American cannabis operator, today announced it has entered into a definitive agreement to acquire GuadCo, LLC and KCR Holdings LLC (collectively “KCR”) for an implied enterprise value of US$70 million (the “transaction”).  Upon close, the transaction will add three retail dispensaries located in BethlehemAllentown and Stroudsburg to complement the Company’s existing retail footprint in Southeastern Pennsylvania.

As an operator of three well managed dispensaries in the Northeast region of Pennsylvania, KCR expands TerrAscend’s retail footprint, diversifies the Company’s customer base and enhances margins through deeper vertical integration. The transaction will be immediately accretive upon closing, which is expected to occur in the second quarter, subject to customary regulatory approvals.

“The Pennsylvania medical cannabis market is a key focus for the Company,” said Jason Wild, Executive Chairman of TerrAscend. “This transaction doubles our owned footprint to six dispensaries in the state and provides patients in Pennsylvania’s Northeast region access to TerrAscend’s outstanding products, service, and support. This expanded retail footprint further solidifies our position as the leading branded cultivator and manufacturer in Pennsylvania.”

Transaction Details
TerrAscend currently owns 10% of KCR and will acquire the remaining 90% of the equity for total consideration of $63 million, comprised of $36 million in stock, $20.25 million in cash and a $6.75 million note. The purchase price is expected to represent a mid-single digit multiple of KCR’s 2021 EBITDA.

The Canadian Securities Exchange (“CSE”) has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

About TerrAscend
TerrAscend is a leading North American cannabis operator with vertically integrated operations in PennsylvaniaNew Jersey, and California in addition to operating as a licensed producer in Canada. TerrAscend operates an award-winning chain of Apothecarium dispensary retail locations as well as scaled cultivation, processing and manufacturing facilities on both the East and West coasts. TerrAscend’s best-in-class cultivation and manufacturing practices yield consistent, high-quality cannabis, providing industry-leading product selection to both the medical and legal adult-use market. The Company owns several synergistic businesses and brands, including The Apothecarium, Ilera Healthcare, Kind Tree, Prism, State Flower, Valhalla Confections, and Arise Bioscience Inc. For more information, visit www.terrascend.com.

Forward Looking Information
This news release contains “forward-looking information” within the meaning of applicable securities laws. Forward-looking information contained in this press release may be identified by the use of words such as, “may”, “would”, “could”, “will”, “likely”, “expect”, “anticipate”, “believe, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook” and other similar expressions, and include statements with respect to future revenue and profits. Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors relevant in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment; and the availability of licenses, approvals and permits.

Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. Such risks and uncertainties include, but are not limited to, current and future market conditions; risks related to federal, state, provincial, territorial, local and foreign government laws, rules and regulations, including federal and state laws in the United States relating to cannabis operations in the United States; and the risk factors set out in the Company’s most recently filed MD&A, filed with the Canadian securities regulators and available under the Company’s profile on SEDAR at www.sedar.com.

The statements in this press release are made as of the date of this release. The Company disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

Caution Regarding Cannabis Operations in the United States
Investors should note that there are significant legal restrictions and regulations that govern the cannabis industry in the United States. Cannabis remains a Schedule I drug under the US Controlled Substances Act, making it illegal under federal law in the United States to, among other things, cultivate, distribute or possess cannabis in the United States. Financial transactions involving proceeds generated by, or intended to promote, cannabis-related business activities in the United States may form the basis for prosecution under applicable US federal money laundering legislation.

While the approach to enforcement of such laws by the federal government in the United States has trended toward non-enforcement against individuals and businesses that comply with medical or adult-use cannabis programs in states where such programs are legal, strict compliance with state laws with respect to cannabis will neither absolve TerrAscend of liability under U.S. federal law, nor will it provide a defense to any federal proceeding which may be brought against TerrAscend. The enforcement of federal laws in the United States is a significant risk to the business of TerrAscend and any proceedings brought against TerrAscend thereunder may adversely affect TerrAscend’s operations and financial performance.

SOURCE TerrAscend

For further information: For more information regarding TerrAscend:  Keith Stauffer, Chief Financial Officer, [email protected]; Daniel Foley, SVP, Treasurer, [email protected]

Related Links

https://www.terrascend.com/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

Ryan Allway

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


]]>